
04 Jun 2022 Policy
Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel
Leukaemia UK is committed to championing advancements in better treatments and care for all. We want to ensure the needs of patients are at the heart of everything we do, and that the voices of people affected by leukaemia and related conditions are being heard.
That is why we have set up a Patient Experience Advisory Panel – to bring the voices of those who have experienced leukaemia to decision-makers in the UK Government and elsewhere and to advocate that every patient has access to the best available therapies.
To do this, we need your help! If you or someone close to you has lived experience of leukaemia or a related condition and you would be interested in participating, please get in touch.
We hope that together we can help to explain to decision-makers what is needed to improve the lives of people living with leukaemia and related disorders and highlight the issues faced by these patients and their families.
You will have the opportunity to share your experience, listen to the experiences of others, and feedback on some of our work. No prior knowledge or skills are necessary and we hope that this will be a rewarding opportunity where you can share your experience in a supportive atmosphere. Your insight and opinions will enable us to continue to focus on what matters most to those who receive a leukaemia or related diagnosis.
If you would like to be involved or if you have any questions, please contact us at info@leukaemiauk.org.uk, using the subject line “Patient Experience”. We look forward to hearing from you!
You can also download the full role description.
Our commitment to you
- We will ensure your participation in the panel is meaningful and put to good use in the work and activity of Leukaemia UK.
- We will always put your wellbeing first and understand if you need to take a break or more distant role from the panel in the future.
- We will work with you to develop ways of working that enhance your participation.
Related posts
21 April 2023
Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers
A pioneering new study hopes to accelerate progress towards a new treatment for acute myeloid leukaemia (AML) in research announced today on World AML Day by Leukaemia UK. University of…
21 June 2023
Prestigious jointly-funded fellowship could be catalyst for myeloma prevention
Dr Louise Ainley, University College London, has been awarded a Clinical Research Training Fellowship – jointly funded with the Medical Research Council. The three-year project is set to investigate which…
6 June 2022
An open letter to people with a weakened immune system
Leukaemia UK joins the NHS and other charity leaders by signing an open letter, to encourage people with a weakened immune system to continue to book in or visit a walk-in centre for their Covid-19 vaccines.
9 May 2018
Sharing this exciting news: a treatment advance for childhood leukaemia
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades